Oral isotretinoin therapy in severe acne induces transient suppression of biochemical markers of bone turnover and calcium homeostasis

Acta Dermato-Venereologica

Volumn 78, Issue 4, 1998, Pages 266-269

  Kindmark, Andreas ^a   Rollman, Ola ^a   Mallmin, Hans ^a   Petrén Mallmin, Marianne ^a   Ljunghall, Sverker ^a   Melhus, Håkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mineral density; Isotretinoin; Retinoic acid; Vitamin A

Indexed keywords

ISOTRETINOIN; PARATHYROID GLAND HORMONE;

ACNE; ADOLESCENT; ADULT; ARTICLE; BONE METABOLISM; BONE MINERAL; BONE TISSUE; BONE TURNOVER; CALCIUM HOMEOSTASIS; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; DIETARY INTAKE; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BONE DENSITY; CALCIUM; FEMALE; HOMEOSTASIS; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 0031870329     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598441837     Document Type: Article

References (26)

1. Wolbach SB. Vitamin-A deficiency and excess in relation to skeletal growth. J Bone Joint Surg 1947; 29: 171-192.
2. Melnik B, Glück S, Jungblut RM, Goerz G. Retrospective radiographic study of skeletal changes after long-term etretinate therapy. Br J Dermatol 1987; 116: 207-212.
3. Burge S, Ryan T. Diffuse hyperostosis associated with etretinate. Lancet 1985; 2: 397-398.
4. Armstrong R, Ashenfelter K, Eckoff C, Levin A, Shapiro S. General and reproductive toxicology of retinoids. In: Sporn, M., Roberts, A., Goodman D, eds. The Retinoids, 2nd ed. New York: Raven Press, 1994; 1: 545-572.
5. Halkier-Sørensen L, Laurberg G, Andresen J. Bone changes in children on long-term treatment with etretinate. J Am Acad Dermatol 1987; 16: 999-1006.
6. DiGiovanna JJ, Sollitto RB, Abangang DL, Steinberg SM, Reynolds JC. Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 1995; 131: 1263-1267.
7. Okada N, Nomura M, Morimoto S, Ogihara T, Yoshikawa K. Bone mineral density of the lumbar spine in psoriatic patients with long term etretinate therapy. J Dermatol 1994; 21: 308-311.
8. Kindmark A, Törmä H, Johansson AG, Ljunghall S, Melhus H. Reverse transcription-polymerase chain reaction assay demonstrates that the 9-cis retinoic acid receptor a is expressed in human osteoblasts. Biochem Biophys Res Comm 1993; 192: 1367-1372.
9. 3-induced bone resorption. Calcif Tissue Int 1995; 57: 242-244.
10. Tangrea JA, Taylor PR, Hartman AM, Edwards BK, Kilcoyne RF, Helsel WE, et al. Isotretinoin and the axial skeleton. Lancet 1992; 340:495-496.
11. Lawson JP, McGuire J. The spectrum of skeletal changes associated with long-term administration of 13-cis-retinoic acid. Skeletal Radiology 1987; 16: 91-97.
12. Margolis DJ, Attie M, Leyden JJ. Effects of isotretinoin on bone mineralization during routine therapy with Isotretinoin for acne vulgaris. Arch Dermatol 1996; 132: 769-774.
13. Rodland O, Aksnes L, Nilsen A, Morken T. Serum levels of vitamin D metabolites in isotretinoin-treated acne patients. Acta Derm Venereol (Stockh) 1992; 72(3): 217-219.
14. Brahm H, Ljunggren Ö, Larsson K, Lindh E, Ljunghall S. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen. Calcif Tissue Int 1994; 55: 412-416.
15. Clark I, Smith MR. Effects of hypervitaminosis A and D on skeletal metabolism. J Biol Chem 1964; 239: 1266-1271.
16. Hough S, Avioli L, Muir H, Gelderblom D, Jenkins G, Kurasi H, et al. Effects of hypervitaminosis A on the bone and mineral metabolism of the rat. Endocrinology 1988; 122: 2933-2939.
17. Ruby LK, Mital MA. Skeletal deformities following chronic hypervitaminosis A. J Bone Joint Surg 1974; 56: 1283-1287.
18. Mørk N-J, Kolbenstvedt A, Austad J. Efficiacy and skeletal side effects of two years' acitretin treatment. Acta Derm Venereol (Stockh) 1992; 72: 445-448.
19. van Dooren-Grebe RJ, Lemmens JAM, de Boo T, Hangx NMA, Kuijpers ALA, van de Kerkhof PCM. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities. Br J Dermatol 1996; 134: 71-76.
20. Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids, 2nd ed. New York: Raven Press, 1994; 1: 443-520.
21. Mundy GR. Osteoblasts, bone formation and mineralization. In: Mundy GR, ed. Bone remodeling and its disorders. London: Martin Dunitz Ltd; 1995: 27-38.
22. Carey BM, Parkin GJ, Cunliffe WJ, Pritlove J. Skeletal toxicity with isotretinoin therapy: a clinico-radiological evaluation. Br J Dermatol 1988; 119: 609-614.
23. Villablanca JG, Khan AA, Avramis VI, Reynolds CP. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid. Am J Pediatr Hematol Oncol 1993; 15: 410-415.
24. Eckhoff C, Collins MD, Nau H. Human plasma all-trans-, 13-cis- and 13-cis-4-oxoretinoic acid profiles during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels. J Nutr 1991; 121: 1016-1025.
25. Tang G, Russel RM. 13-cis retinoic acid is an endogenous compound in human serum. J Lipid Res 1990; 30: 175-182.
26. Rollman O, Vahlquist A. Oral isotretinoin (13-cis retinoic acid) therapy in acne: drug and vitamin A concentrations in serum and skin. J Invest Dermatol 1986; 86: 384-389.